JAMA news releases are made available to the public after 3 pm US Central time on the first 4 Tuesdays of each month. The Archives Journals news releases are made available to the public after 3 pm Central time on Mondays. We also provide a list of previous news releases.
THIS WEEK'S CONTENT
JAMA NEWS RELEASES
(Embargoed for Release: 3 p.m. CT, Tuesday, June 15, 2004)
JAMA NEWS RELEASES
STATINS NOT AS EFFECTIVE FOR INDIVIDUALS WITH CERTAIN GENETIC VARIATIONS
LEAN TEENS MORE LIKELY TO COMPENSATE FOR OVEREATING FAST FOOD THAN OVERWEIGHT PEERS
LATEST REPORT SHOWS PREVALENCE OF OVERWEIGHT AMONG CHILDREN AND OBESITY AMONG ADULTS NOT DECREASING
USE OF LASER THERAPY DOES NOT SIGNIFICANTLY IMPROVE ACNE
IN-PERSON DRIVER'S LICENSE RENEWAL ASSOCIATED WITH LOWER DEATH RATE AMONG ELDERLY DRIVERS
INFORMATION CONTAINED IN THESE NEWS RELEASES IS PROTECTED BY COPYRIGHT. JOURNAL ATTRIBUTION IS REQUIRED.
TV Note: This week's JAMA video news release is on compensating for calorie intake from fast food for overweight and lean teenagers. The release will be fed Tuesday, June 15, from 9:00 - 9:30 a.m. ET on Telstar 6, Transponder 11 (C-Band) and from 2:00 - 2:30 p.m. ET on Telstar 6, Transponder 11 (C-Band). For more information, call 312/464-JAMA (5262).
Please Note: Our e-mail has changed to
mediarelations{at}jama-archives.org
JOURNALISTS CAN NOW ACCESS EMBARGOED JAMA/ARCHIVES STUDIES ONLINE
Go to www.jamamedia.org for more information and to apply for access.
Please Note: The FOR THE MEDIA Web site now has a search feature to enable media to find previous JAMA/Archives news releases on specific medical topics. This search feature link is located on the home page at www.jamamedia.org
SAVE THE DATE: New research from JAMA's theme issue on HIV/AIDS will be presented at the 15th International AIDS Conference in Bangkok, Thailand, on Sunday, July 11, from 9 a.m. to 11 a.m., at the Oriental Hotel in Bangkok. A program and registration form will be included in a future email.
Embargoed for Release: 3 p.m. CT, TUESDAY, June 15, 2004
Media Advisory: To contact corresponding author Paul M. Ridker, M.D., M.P.H., call Amy Dayton at 617-534-1603. To contact commentary author Susanne B. Haga, Ph.D., call 301-309-3400.
STATINS NOT AS EFFECTIVE FOR INDIVIDUALS WITH CERTAIN GENETIC VARIATIONS
CHICAGOPersons with certain genetic variations who take statins to lower their cholesterol will not realize the same benefit as other individuals, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
Therapy with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) lowers total and low-density lipoprotein (LDL) cholesterol and has proven to be highly effective for cardiovascular risk reduction, according to background information in the article. However, there is wide variation in interindividual response to statin therapy, and it has been hypothesized that genetic differences may contribute to this variation.
Daniel I. Chasman, Ph.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues conducted a study to determine whether common genetic variants influence the degree of lipid level reduction during pravastatin therapy. The study included 1,536 individuals treated with pravastatin, 40 mg/per day. Their DNA in blood samples was analyzed for 148 single-nucleotide polymorphisms (SNPs) within 10 candidate genes related to lipid metabolism. Variation within these genes was then examined for associations with changes in lipid levels observed with pravastatin therapy during a 24-week period.
"In this analysis of 148 SNPs across 10 genes known to be involved in cholesterol synthesis and statin metabolism, we found 2 common and closely linked polymorphisms in the HMG-CoA reductase gene that were significantly associated with a 22 percent smaller reduction in total cholesterol and a 19 percent smaller reduction in LDL cholesterol following 24 weeks of pravastatin therapy," the authors write. "For total cholesterol, these effects remained significant after adjustment for all SNPs evaluated and were consistent in magnitude and direction among men and women and among whites as well as the total cohort."
"We recognize that these data have considerable pathophysiologic interest and provide strong clinical evidence that there may be promise in the concept of 'personalized medicine' and the use of genetic screening to target certain therapies. The absolute difference in total cholesterol reduction associated with the HMG-CoA reductase genotype in our data was 9 mg/dL (0.23 mmol/L), an effect large enough to affect health on a population basis. Future studies must determine whether this difference can be offset by dose adjustment or the choice of an alternative nonstatin lipid-lowering therapy. In the meantime, clinical reminders to take treatment daily and to titrate dose as necessary to achieve National Cholesterol Education Program goals remain critical issues for practice," the authors conclude.
(JAMA. 2004;291:2821-2827. Available post-embargo at jama.com)
Editor's Note: Components of this work were supported by grants from the National Heart, Lung, and Blood Institute, the Doris Duke Charitable Foundation (New York, N.Y.), the Fondation Leducq (Paris), the Donald W. Reynolds Foundation (Las Vegas), and Bristol-Myers Squibb. Authors Chasman, Posada, Stanton and Subrahmanyan were employees of Variagenics Inc. when this project was initiated. Dr. Ridker received research support from Variagenics Inc. for portions of this work. Variagenics Inc. no longer exists.
COMMENTARY: USING PHARMACOGENETICS TO IMPROVE DRUG SAFETY AND EFFICACY
In an accompanying commentary, Susanne B. Haga, Ph.D., of the Center for the Advancement of Genomics, Rockville, Md., and Wylie Burke, M.D., Ph.D., of the University of Washington, Seattle, write that assessing the clinical implications of pharmacogenetic research will be a complex task.
"The individual response to drugs is multifactorial, due to interactions between extrinsic (e.g., environment, lifestyle) and intrinsic (e.g., sex, underlying disease, genetic predisposition) factors. Pharmacogenetic studies on drug-target interaction (pharmacodynamics) or drug metabolism (pharmacokinetics) are already yielding substantial information about the influence of genetic variation on drug response. However, the clinical use of such information-tailoring treatment of the individual patient based on genotype-must be based on empirical evidence that pharmacogenetic tests improve health outcomes."
The authors add that "by guiding drug therapy, pharmacogenetic testing could help to prevent serious injuries, hospitalization, mortality, and health care costs associated with adverse drug responses, and avoid the cost and inconvenience of prescribing drugs to patients who are likely to be nonresponders."
"Although the health outcomes of pharmacogenetics are untested, this technology has the potential to improve the safety and efficacy of commonly used drugs. An efficient research program could yield benefits in a relatively short period, representing a substantial contribution to the public's health. But neither market forces nor academic incentives are likely to produce the quality or type of data needed to proceed with confidence. An active effort is needed to ensure a rigorous assessment of this promising application of genomic technology, through partnerships and collaborative efforts among the federal, academic, and private sectors or, possibly, enhanced regulations," they conclude.
(JAMA. 2004; 291:2869-2871. Available post-embargo at jama.com)
Editor's Note: This work was supported in part by a grant from the National Human Genome Research Institute and the University of Washington Center for Ecogenetics and Environmental Health and by a grant from the National Institute for Environmental Health Sciences. Dr. Haga owns stock in Pfizer Inc., Wyeth, Corixa Corp., Chiron Corp., Human Genome Sciences Inc., Agilent Technologies, Incara Pharmaceuticals, Array BioPharma, and Peregrine Pharmaceuticals.
For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org (please note new email address).
Go back to the top.
Embargoed for Release: 3 p.m. CT, TUESDAY, June 15, 2004
Media Advisory: To contact corresponding author David S. Ludwig, M.D., Ph.D., call Elizabeth Andrews at 617-355-5332.
LEAN TEENS MORE LIKELY TO COMPENSATE FOR OVEREATING FAST FOOD THAN OVERWEIGHT PEERS
CHICAGOAdolescents are more likely to overeat when served fast food, but lean adolescents tend to compensate for the over-consumption by eating less at other meals, which is not something their overweight counterparts are likely to do, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
"Consumption of fast food has increased rapidly since the 1970s among adolescents from all socioeconomic and racial/ethnic groups across the United States," the authors provide as background information in the article. "An estimated 75 percent of adolescents eat fast food one or more times per week. The increase in fast food consumption parallels the escalating obesity epidemic, raising the possibility that these 2 trends are causally related," the authors suggest. "Characteristics of fast food previously linked to excess energy intake [overeating] or adiposity [fat] include enormous portion size, high energy density, palatability, excessive amounts of refined starch and added sugars, high fat content, and low levels of dietary fiber."
In this study, Cara B. Ebbeling, Ph.D., from Children's Hospital, Boston, and colleagues conducted two studies to evaluate the effects of fast food on energy intake in overweight versus lean adolescents. Fifty-four adolescents were enrolled in the studies (26 overweight, 28 lean) aged 13 to 17 years who reported eating fast food at least one time per week. Fifty-one (24 overweight, 27 lean) of the 54 participants enrolled in study 1 also completed study 2. In this investigation, the researchers grouped adolescents who were overweight and at risk of overweight into one group and adolescents with a BMI [body mass index = weight in kilograms divided by the square of height in meters] not exceeding the 85th percentiles for their ages were considered lean.
In study one, participants were fed extra large fast food meals in a food court and instructed to eat as much or as little as desired during the one-hour meal. In study two, the researchers assessed how much food was eaten under free-living conditions for two days when fast food was consumed and two days when it was not consumed. The participants recalled dietary and physical activity on telephone interviews. Data were collected between July 2002 and March 2003.
"In study 1, mean [average] energy intake from the fast food meal among all participants was extremely large (1,652 kcal =calories), accounting for 61.6 percent of estimated daily energy requirements," the researchers found. "Overweight participants ate more than lean participants whether energy was expressed in absolute terms (1,860 vs. 1,458 kcal) or relative to estimated daily energy requirements (66.5 percent vs. 57 percent). In study 2, overweight participants consumed significantly more total energy on fast food days than non-fast food days (2,703 vs. 2,295 kcal/d; plus 409 kcal/d), an effect that was not observed among lean participants (2,575 vs. 2,622 kcal/d; less 47 kcal/d)." The researchers also found that overweight participants tended to under-report total energy intake compared with lean participants.
"...the overweight participants consumed more total energy on days with than without fast food, in contrast to the lean participants, who consumed virtually the same amount on both days. This observation suggests that overweight individuals do not compensate completely for the massive portion sizes characteristic of fast food today," the author note. "… these findings suggest that, at least, fast food consumption serves to maintain or exacerbate obesity in susceptible individuals."
"In this study, adolescents overconsumed fast food regardless of body weight, although this phenomenon was especially pronounced in overweight participants. Moreover, overweight adolescents were less likely to compensate for the energy in fast food, by adjusting energy intake throughout the day, than their lean counterparts," the authors conclude.
(JAMA. 2004;291:2828-2833. Available post-embargo at jama.com)
Editor's Note: This study was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, Md.); the Charles H. Hood Foundation (Boston, Mass.); and a grant awarded by the National Institutes of Health (Bethesda, Md.) to support the General Clinical Research Center at Children's Hospital (Boston, Mass.).
For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org
Go back to the top.
Embargoed for Release: 3 p.m. CT, TUESDAY, June 15, 2004
Media Advisory: To contact Allison A. Hedley, Ph.D., call Jeff Lancashire at 301-458-4800.
LATEST REPORT SHOWS PREVALENCE OF OVERWEIGHT AMONG CHILDREN AND OBESITY AMONG ADULTS NOT DECREASING
CHICAGOThe high levels of overweight among children and obesity among adults remain a major public health concern, according to a report in the June 16 issue of the Journal of the American Medical Association (JAMA).
According to background information in the article, "The prevalence of overweight and obesity is considered an important public health issue in the United States. Healthy People 2010 identified overweight and obesity as one of the 10 leading health indicators."
Allison A. Hedley, Ph.D., from the Centers for Disease Control and Prevention, Atlanta, and colleagues updated the U.S. prevalence estimates of overweight in children and obesity in adults using the most recent national data of height and weight measurements. The researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES), a probability sample of the U.S. non-institutionalized civilian population. Both height and weight measurements were obtained from 4,115 adults and 4,018 children in 1999 - 2000 and from 4,390 adults and 4,258 children in 2001-2002.
"For adults, overweight, obesity, and extreme obesity, were defined as body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters) of 25.0 to 29.9, 30.0 or more, and 40.0 or more, respectively." For children, "at risk for overweight was defined as at or above the 85th percentile but less than the 95th percentile of the sex-specific BMI for age", as defined by the CDC growth charts. "Overweight was defined as at or above the 95th percentile of the sex-specific BMI-for-age growth chart."
"Between 1999 - 2000 and 2001 - 2002, there were no significant changes among adults in the prevalence of overweight or obesity (64.5 percent vs. 65.7 percent), obesity (30.5 percent vs. 30.6 percent), or extreme obesity (4.7 percent vs. 5.1 percent), or among children aged 6 through 19 years in the prevalence of at risk for overweight or overweight (29.9 percent vs. 31.5 percent) or overweight (15.0 percent vs. 16.5 percent)," the authors found. "Overall, among adults aged at least 20 years in 1999 - 2002, 65.1 percent were overweight or obese, 30.4 percent were obese, and 4.9 percent were extremely obese. Among children aged 6 through 19 years in 1999 - 2002, 31 percent were at risk for overweight or overweight and 16 percent were overweight."
"The prevalence of obesity by age, sex, and racial/ethnic group ranged from 22.9 percent of non-Hispanic white men aged 20 through 39 years to 50.6 percent of non-Hispanic black women aged 40 through 59 years. Among women, non-Hispanic black women had the highest level of extreme obesity (13.5 percent) compared with 5.5 percent and 5.7 percent of non-Hispanic white and Mexican American women, respectively. There was no significant difference in the prevalence of obesity among men across racial/ethnic categories for all age groups. Among women aged at least 20 years, the prevalence of obesity differed significantly between racial/ethnic groups, with non-Hispanic white women having the lowest prevalence (30.7 percent), non-Hispanic black women having the highest (49.0 percent), and the prevalence among Mexican American women falling in between (38.4 percent). The prevalence of obesity was significantly higher among women than men."
In conclusion the authors write, "Substantial progress will need to be made in the efforts to lower the prevalence of overweight and obesity if the goals of Healthy People 2010 are to be met."
(JAMA. 2004; 291:2847-2850. Available post-embargo at jama.com)
For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org
Go back to the top.
Embargoed for Release: 3 p.m. CT, TUESDAY, June 15, 2004
Media Advisory: To contact Jeffrey S. Orringer, M.D., call Nicole Fawcett at 734-764-2220.
USE OF LASER THERAPY DOES NOT SIGNIFICANTLY IMPROVE ACNE
CHICAGOAdditional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
Acne is a common disorder that has the potential to negatively affect the lives of millions of individuals, according to information in the article. In addition to the sometimes more short-term consequences of physical and emotional discomfort associated with this condition, acne also carries the risk of scarring that may serve as a permanent reminder of the disorder and thus prolong its psychological impact. Therefore, the development of safer, more convenient, and more effective treatments for acne is highly desirable. Treatment with various lasers has been reported to improve acne.
Jeffrey S. Orringer, M.D., and colleagues with the University of Michigan Medical School, Ann Arbor, Mich., evaluated the clinical efficacy of a type of laser treatment, pulsed dye laser therapy, for the treatment of acne.
The study was a randomized, controlled, clinical trial that included 40 patients aged 13 years or older with facial acne, conducted at an academic referral center from August 2002 to September 2003. Patients received one or two pulsed dye laser treatments to half of the face. The degree of acne was measured through blinded clinical assessments (lesion counts) and the use of standardized bilateral serial photographs comparing the treated and untreated sides of the face.
The researchers found no significant improvement in facial acne from the laser treatment. Changes in lesion counts for both sides of the face showed no statistically significant differences from baseline to week 12. Grading of serial photographs confirmed the clinical assessments.
"The fact that our study does not substantiate the positive results recently reported [in other studies] is not an indictment of laser therapy for acne in general, and does not necessarily rule out the possible role of this particular pulsed dye laser. However, it does suggest that additional well-designed studies are needed before the use of the pulsed dye laser becomes a part of acne therapy," the authors conclude.
(JAMA. 2004;291:2834-2839. Available post-embargo at jama.com)
Editor's Note: The research for this article was supported by the Babcock Endowment for Dermatological Research at the University of Michigan, ICN Pharmaceuticals Inc., a Dermatology Foundation Clinical Career Development Award in Dermatologic Surgery to Dr. Orringer, and a National Institutes of Health grant to co-author Dr. Kang.
For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org
Go back to the top.
Embargoed for Release: 3 p.m. CT, TUESDAY, June 15, 2004
Media Advisory: To contact David C. Grabowski, Ph.D., call Joy Carter at 205-934-1676.
IN-PERSON DRIVER'S LICENSE RENEWAL ASSOCIATED WITH LOWER DEATH RATE AMONG ELDERLY DRIVERS
CHICAGOStates with in-person license renewal policies had a 17 percent lower fatality rate among drivers 85 years and older than states without, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
According to background information in the article, motor vehicle death rates among older drivers have been increasing over the past two decades and are expected to account for up to 25 percent of total driver deaths in the year 2030, compared to 14 percent currently. In addition, elderly drivers have more deadly crashes per mile driven than any other group except teenage males.
David C. Grabowski, Ph.D., and colleagues from the University of Alabama at Birmingham, conducted a study examining states' license-renewal laws and fatal motor vehicle accidents involving older drivers in the United States. The researchers used data from the Fatality Analysis Reporting System (FARS), collected from January 1990 to December 2000 by the National Highway Traffic Safety Administration, which includes in-depth information on cars, drivers, and passengers involved in fatal motor vehicle accidents. In addition to in-person renewal laws, the researchers also studied the effect of vision tests, roads tests, and frequency of license renewal on elderly driver deaths.
There were 4,605 driver fatalities throughout the 11-year study period for drivers 85 years of age or older. The researchers found that states with mandated in-person license renewal laws had a 17 percent lower death rate among this age group than those states without such laws. However, the researchers also found that "vision tests, road tests, and more frequent renewals [were] not independently associated with additional safety benefits." In 2000, 45 states had in-person renewal laws, 40 states required vision tests and 2 states required road tests at the time of license renewal for older drivers.
"It is important to note that in-person renewal allows driver license examiners the opportunity to refer certain older drivers for medical evaluation, and some of these evaluations may include more sophisticated testing such as neurological examinations, comprehensive visual examinations, simulator tests, and road tests," the authors write. "… the results of this study support the importance of in-person license renewal for older adults as a potential mechanism toward decreasing the fatality crash rate among the oldest old drivers."
(JAMA. 2004;291:2840-2846. Available post-embargo at jama.com)
Editor's Note: This study was supported by grants from the University Transportation Center for Alabama; the Centers for Disease Control and Prevention, National Center for Injury Prevention and Control to the Injury Control Research Center at the University of Alabama at Birmingham.
For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org
Go back to the top.
JAMA VIDEO NEWS REPORT
LEAN TEENS COMPENSATE FOR EATING FAST FOOD BY EATING LESS CALORIES THROUGHOUT THE DAY - OVERWEIGHT TEENS DON'T COMPENSATE
VIDEO:
Tara and friends eating fast food at table on patio
AUDIO:
SIXTEEN-YEAR OLD TARA SEARIGHT (SEE-RITE) EATS FAST FOOD ABOUT ONCE A WEEK. SHE ESPECIALLY LOVES FRIES. BUT SHE STAYS AT A HEALTHY WEIGHT, IN PART BY COMPENSATING FOR THE FAST FOOD SHE EATS.
VIDEO:
SOT/FULL
@ : 11
Super: Tara Searight, Eats fast food weekly
Runs :08
AUDIO:
"If I have fast food for lunch, I'll definitely try to have something healthier for dinner like a salad, or put in some extra fruits and vegetables."
VIDEO:
B-ROLL
Tara and friends walking out of fast food restaurant
GFX/JAMA COVER
Dr. Ebbeling at computer going over data
AUDIO:
THAT KIND OF COMPENSATING IS ONE DIFFERENCE BETWEEN LEAN TEENS AND OVERWEIGHT ONES, ACCORDING TO A NEW STUDY IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. DR. CARA EBBELING (EBB-el-ing) AUTHORED THE STUDY, ALONG WITH FELLOW RESEARCHERS AT CHILDREN'S HOSPITAL IN BOSTON, AND A COLLEAGUE FROM UNIVERSITY OF MINNESOTA.
VIDEO:
SOT/FULL
@ :36
Super: Cara Ebbeling, Ph.D., Children's Hospital, Boston
Runs :17
AUDIO:
"When lean adolescents eat a large fast food meal, they seem to compensate for the calories in the meal by eating less of other food throughout the day. In contrast, obese adolescents do not seem to compensate."
VIDEO:
B-ROLL
Tara and friends eating fast food at table on patio
Teens of varying weights playing badminton in school gym
AUDIO:
THE RESEARCHERS MEASURED HOW MANY CALORIES TEENS CONSUME DURING A LARGE FAST FOOD MEAL. THEY ALSO TRACKED HOW MANY CALORIES WERE CONSUMED DURING DAYS WHEN TEENS ATE FAST FOOD, COMPARED TO DAYS WHEN TEENS DID NOT. BOTH LEAN AND OVERWEIGHT TEENS PARTICIPATED IN THE STUDY.
VIDEO:
SOT/FULL
Cara Ebbeling, Ph.D., Children's Hospital, Boston
Runs :17
AUDIO:
"Obese adolescents had a particular problem compensating for the calories in a large fast food meal, such that they consumed 400 more calories on days when they had a fast food meal compared to days when they did not."
VIDEO:
B-ROLL
Teens eating fast food
AUDIO:
THE STUDY FOUND THAT DURING A SINGLE LARGE FAST FOOD MEAL, WITH ITS HIGH FAT, STARCH AND SUGAR AND LOW FIBER CONTENT, TEENS CONSUMED SIXTY PERCENT OF THEIR DAILY CALORIE NEEDS.
VIDEO:
SOT/FULL
Tara Searight, Eats fast food weekly
Runs :10
AUDIO:
"Every time I eat fast food I keep thinking this is awful for me. I know this is awful for me and I just can't stop because it tastes so good."
VIDEO:
B-ROLL
Tara eating fast food
AUDIO:
SHE'LL LIKELY KEEP EATING IT, BUT COMPENSATE BY EATING HEALTHIER FOODS AS WELL. THIS IS MAVIS PRALL REPORTING.